| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99499 |
|
4,005 |
3,185 |
$350K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
7,707 |
4,978 |
$82K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,497 |
3,473 |
$81K |
| 99199 |
Unlisted special service, procedure or report |
825 |
345 |
$67K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,246 |
984 |
$36K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,886 |
1,343 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,137 |
878 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
545 |
458 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
376 |
277 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
263 |
195 |
$4K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
57 |
51 |
$3K |
| 99201 |
|
80 |
78 |
$483.23 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17 |
15 |
$362.81 |
| 2023F |
|
15 |
14 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
19 |
18 |
$0.00 |